Celgene, Evotec in $295-Million Pact for Neurodegenerative Diseases
By
Celgene has formed a collaboration with Evotec, a Hamburg, Germany-based drug-discovery company, to identify disease-modifying therapeutics for neurodegenerative diseases. The collaboration will initially focus on amyotrophic lateral sclerosis, Alzheimer’s disease,…